Jiménez Fonseca, P., Foy, V., Raby, S., Carmona-Bayonas, A., Macía-Rivas, L., Arrazubi, V., . . . Gallego Plazas, J. (2023). The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy.
Citación estilo ChicagoJiménez Fonseca, Paula|||0000-0003-4592-3813, et al. The AGAMENON-SEOM Model for Prediction of Survival in Patients With Advanced HER2-positive Oesophagogastric Adenocarcinoma Receiving First-line Trastuzumab-based Therapy. 2023.
Cita MLAJiménez Fonseca, Paula|||0000-0003-4592-3813, et al. The AGAMENON-SEOM Model for Prediction of Survival in Patients With Advanced HER2-positive Oesophagogastric Adenocarcinoma Receiving First-line Trastuzumab-based Therapy. 2023.